论文信息 - Multi-omics profiling establishes the polypharmacology of FDA Approved CDK4/6 inhibitors and its impact on drug response - 字舞流文

Multi-omics profiling establishes the polypharmacology of FDA Approved CDK4/6 inhibitors and its impact on drug response

Sarah A. Boswell | P. Sorger | R. Everley | D. Juric | M. Hafner | Mirra Chung | K. Subramanian | Changchang Liu | C. Walmsley | Chen Chen | Caitlin E. Mills